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A comparative study of the compositional properties of
various protein sets from both cellular and viral organisms
is presented. Invariants and contrasts of amino acid usages
have been discerned for different protein function classes and
for different species using robust statistical methods based
on quantile distributions and stochastic ordering relationships.
In addition, a quantitative criterion to assess amino acid
compositional extremes relative to a reference protein set is
proposed and applied. Invariants of amino acid usage relate
mainly to the central range of quantile distributions, whereas
contrasts occur mainly in the tails of the distributions,
especially contrasts between eukaryote and prokaryote
species. Influences from genomk. constraint are evident, for
example, in the argininerlysine ratios and the usage
frequencies of residues encoded by G + C-rich versus
A + T-rich codon types. The structurally similar amino adds,
glutamate versus aspartate and phenylalanine versus tyrosine,
show stochastic dominance relationships for most species
protein sets favoring glutamate and phenylalanine
respectively. The quantile distribution of hydrophobk amino
acid usages in prokaryote data dominates the corresponding
quantile distribution in human data. In contrast, glutamate,
cysteine, proline and serine usages in human proteins
dominate the corresponding quantile distributions in
Escherichia colt. E.coli dominates human in the use of basic
residues, but no dominance ordering applies to acidic
residues. The discussion centers on commonalities and
anomalies of the amino acid compositional spectrum in
relation to species, function, cellular localization, biochemical
and steric attributes, complexity of the amino acid biosyn-
thettc pathway, amino acid relative abundances and founder
effects.
Key words: amino acid usages/quantile distributions/weak and
strong amino acid codon types
Introduction
Detailed knowledge of amino acid (aa) usage within and among
protein sets may assist in appraising a particular sequence. For
example, if a certain protein is reported to be rich (or poor) in
a given aa type, one would like to know how significant this cir-
cumstance is among a broad collection of proteins from a similar
source. From this perspective, invariants and contrasts with
respect to aa usage are identified and interpreted for protein
sequence collections of several species, including human,
Drosophila, yeast, Escherichia coli and Bacillus subtilis; for open
reading frames (ORFs) in three large human virus genomes,
human cytomegalovirus (CMV), Epstein—Barr virus (EBV) and
vaccinia; for various human protein subclasses (e.g. nuclear,
glycoprotein and enzyme); and for E.coli enzyme.
Our motivation for these analyses derives from an interest in
the following biological and evolutionary issues: (i) How do aa
usages compare and contrast across species, say E.coli versus
human, E.coli versus B.subtilis!; (ii) What is the nature of aa
usage per protein in relation to function, cellular localization,
evolutionary history and other biological criteria?; (iii) How do
aa usages of similar biochemical, charge or steric attributes relate?
For example, how do the quantile distributions compare for Lys
and Arg (both positively charged), for Asp and Glu (both
negatively charged), for Gly and Ala (bodi of small size), for
Ser and Thr (having similar post-translational modification
potential), for the amide side chains residues Gin and Asn, among
strongly hydrophobic amino acids (Leu, He, Val, Phe, Met) and
for relationships related to evolutionary substitutability?; (iv) other
perspectives on aa compositional preferences relate to the
complexity of the biosynthetic pathways for the different aa, to
aa relative abundances, to aa distributions along the sequences,
to intra and extracellular pH, to codon biases, and to founder
effects.
Residue usage across protein subsets has been the subject of
a number of comparative studies. Sueoka (1960) noticed a general
correlation between deoxynucleotide and aa composition for a
variety of organisms. King and Jukes (1969) determined the aa
composition of 53 vertebrate polypeptides (total 5492 residues)
and claimed, excepting arginine, concordance of observed
frequencies with expectations derived from random codon
choices. Nakashima et al. (1986) investigated the influence of
folding types on residue usage. Doolittle (1986, pp. 55-59)
compared the aa composition of E.coli and human protein
sequences and observed the reduced use of cysteine in E.coli
(putatively all prokaryotes versus higher eukaryotes). McCaldon
and Argos (1988) organized peptides ranging from 2 to 11
residues and projected certain preferences in protein sequences.
Dcemura et al. (1990) and D'Onofrio et al. (1991) analyzed the
aa composition of individual mammalian proteins under the
isochore hypothesis (see also Aissani et al., 1991). All these
comparative studies have centered on average residue usages of
different protein collections.
Our results are based on more robust quantile distributions and
stochastic ordering concepts applied to different amino acid
classifications. For a given residue type (e.g. individual aa,
cationic, anionic, aggregate hydrophobics) and a given protein
collection C (e.g. all protein sequences of a particular species
or function class), a histogram of use for the residue type was
generated. Concretely, for each protein sequence of C, the
frequency of the residue type in the sequence was determined
and the totality of all these frequencies was described by a
histogram of the given residue usage with respect to C. The
quantile distribution is the cumulative representation of this
histogram. Thus, the quantile distribution Q(x) of a given residue
type for a given set of proteins indicates the fraction of proteins
in which that residue type occurs with a frequency ^x%. The
medians (the 0.50 quantile point) and 80% quantile range
(corresponding to the 0.10—0.90 quantile levels) are major
statistical measurements. The 0.01, 0.05, 0.95 and 0.99 quantile
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points of aa usage provide standards by which to assess extremes
of aa usage for any particular protein or protein family. Quantile
distributions for the different protein sets were determined for
each individual aa (Tables I and D), for the aa groups of positively
and negatively charged residues and for total and net charge
values (Table HI), for the aggregate of the major hydrophobic
aa (Table IV) and for strong and weak aa codon types (Table V)
(see Materials and methods).
Materials and methods
Data
Protein sets were compiled from SWISS-PROT release 17
(Bairoch and Boeckmann, 1991). Duplicate and highly similar
sequences were culled to remove redundancies with the aid of
the program PROSET (Brendel, 1992). The fruit fly and yeast
sets respectively contain proteins from D.melanogaster and
Table I. Quantile distributions of amino acid usages in different species
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Amino acid usage in protein classes
Saccharomyces cerevisiae only. The viral protein sequences
correspond to known ORFs. Several nonexclusive protein subsets
were defined relying on the SWISS-PROT keyword index
encompassing the human nuclear subset, a human glycoprotein
subset and human and E.coli enzyme subsets. In every data set
sequences shorter than 200 residues were excluded to reduce
statistical fluctuations. This length limitation excluded ~25%
of all proteins. Only — 10% of enzymes fall below the 200 aa
TaWe II. Quantile distributions of amino acid usages in different subclasses
of human and E.coli proteins
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criterion. Small proteins might differ in their aa composition from
the bulk sequences. However, proteins of small size would, with
> 20 aa types, produce a preponderance of outlier observations,
thus distorting the statistical analysis.
Quantile distributions and stochastic orderings
For each residue type and a specified protein class C of an
organism, the quantity y = Q(x) is the fraction of proteins of
C which carry the specified residue type at a frequency at most
x. The quantile distributions are displayed for the quantile levels
y = min., 0.01, 0.05, 0.10, 0.25, 0.50, 0.75, 0.90, 0.95, 0.99,
max., as representatitive of the whole distribution relative to the
appropriate class of proteins and residue types. The distributions
are not Gaussian and for most aa the standard deviation is larger
than what would be expected from the mean aa frequency and
a protein size distribution based on a binomial model. A quantile
distribution £)(•) is said to be stochastically larger than the
quantile distribution Q{-) if Q(x) < Q(x) for all x. This rela-
tion implies that at each y the usage x corresponding to the quantile
distribution Q() exceeds the usage corresponding to the
quantile distribution Q{-) and, more generally, each monotone
transformation on levels of usage is similarly ranked; for statistical
elaborations see Pe£arid et al. (1992). Stochastic dominance is
TaWe HI. Quantile distributions of charge types in different species and
viral protein sets
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Table IV. Quantile distributions of major hydrophobic residue usage in
different protein sets
Table VI. Outlier statistics1
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Table V. Quantile distributions of strong and weak codon type amino acids
in different protein sets
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designated by >• (see Figures 1 and 4 for examples). A quantile
distribution Q is said to be a stochastic dilation (more spread)
of Q (designated Q : » Q) if Q and Q have about equal means
and the plot of Q(x) crosses the plot of (Rx) once from below
to above as x traverses its domain. The notion of stochastic
dilation provides information about the relative degree of spread
comparing the two distributions. Thus, Q ^S> Q entails that the
distribution Q has a larger variance than the distribution Q and,
more generally, the expectation of any convex function of the
variable x is larger for Q than for Q.
Compositional anomalies (outliers)
The usage of a given aa type in a protein sequence of length N
is considered anomalously high or low if its number of
occurrences is three binomial standard deviations above or below
the 0.9 and 0.1 quantile points respectively of an appropriate
reference set, the binomial standard deviation being defined as
\J(x*)(l — x*)N where x* is the frequency of the aa type
satisfying Q(x*) = 0.9 or Q(x*) = 0.1 respectively.
Amino acid
E
D
K
R
H
L
I
V
M
F
Y
W
P
G
A
S
T
Q
N
C
Total no. of proteins
No. of proteins with outliers
of any kind
Percentages
No. of proteins of outlier status
human
high
20
5
14
5
3
6
2
1
-
2
1
2
20
18
6
8
9
11
7
12
751
114
15
low
—
1
3
2
-
8
2
3
-
2
1
-
3
1
1
3
2
-
4
-
.2
Drosophila
high low
6
- -
2
2
2
2
1
1
1
- -
1
- -
6 3
-
6 2
2 1
1 1
6
4
6
227
45
19.8
yeast
high
3
6
2
1
1
-
1
-
1
-
1
-
4
1
2
7
4
11
8
1
431
43
low
1
-
-
1
-
3
2
2
-
1
1
-
2
-
1
-
1
-
-
-
10.0
E.coli
high low
1 1
-
- -
- -
1
5
1
1
- -
4
4
2
2 1
1
2
2
1
2
1
3
710
30
4.7
"For definition see Materials and methods.
Results
Tables I—V display the quantile distributions of individual aa
usage, cationic, anionic, and aggregate hydrophobic usage and
usage of residues classified by codon type. Sample sizes (number
of sequences) for each set in Table I exceed 110, reaching 751
sequences for the human collection and 710 sequences for the
E. coli data; only sequences of at least 200 residues are considered
(see Materials and methods).
Some of the quantile distributional differences reflect on the
sample sizes and the codon compositional biases extending from
yeast (overall genomic G + C% = 41%), B.subtilis ( = 43%),
E.coli ( = 52%), human ( = 53%) and Drosophila (=55%)
(Cherry, 1991). The human viral genomes of CMV and vaccinia
differ sharply in G + C content, 58% and 38% respectively.
Medians and central 80% quantile range
For all categories of aa usage and organism type, the mean and
median values are close, generally showing a slightly greater
mean. The 0.1—0.9 quantile ranges for most aa types tend to
be of similar length across species. The medians of negatively
charged residues over most species are about 11.4-12.2%, but
the human high extreme levels have substantially higher usage
frequencies, 0.99 quantile = 23.0% compared with 16.2% in
E.coli.
Amino acids of most and least frequent usage for various
species
The most frequently used aa (in terms of mean and median values)
in almost all species is Leu, although in E.coli Ala is a virtual
tie. The least frequently used aa is, generally, Trp in the
eukaryotic species and in the viruses, and Cys in the prokaryotes,
E.coli and B.subtilis. Cys, generally, is used - 1 % in the
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Fig. 1. Glycine and alanine quantile distributions in human and E.coli. Note that stochastic ordering implies nonintersecting distribution functions with the
stochastically bigger distribution entirely on the right side.
unicellular species compared with >2% in the higher eukaryotes.
Cys usage entails quantile distributions that markedly deviate bet-
ween human and Ecoli. Nearly 10% of the E.coli proteins, com-
pared with - 5 % of the human proteins, are devoid of Cys
residues. At the high extreme, E.coli lacks Cys-rich proteins
(99% quantile = 3.8%), whereas the 99% quantile = 7.4% in
the human protein collection.
Charged amino acid usages
The 0.1 -0 .9 quantile points of negatively and positively charged
aa are largely concordant in all the species examined. The extreme
values (corresponding to the quantile points 0.01, 0.05, 0.95 and
0.99) show substantial variation between species (especially for
unicellular versus multicellular species).
Although the aggregate average positive charge frequency per
protein is approximately constant across species, -11 .5%, Lys
and Arg individually vary substantially. Thus, Arg is less frequent
(actually stochastically smaller; Figure 3) in human compared
with E.coli proteins. The human nuclear proteins (Tables II and
HI), on average, contain relatively more positively charged
residues than the overall human protein sequences and 2% more
than cationic occurrences in human glycoproteins.
The median and mean uses of acidic residues (D + E) are
nearly invariant across species, confined to the range
11.2-13.2%, with Eon average 6.4% and Don average 5.5%.
It seems paradoxical that of the quantile charge tables, CMV
proteins use on average the fewest acidic residues (9.5%),
although CMV incorporates eight ORF sequences containing
hyper acidic charge runs (a hyper charge run is an extremely
long run including at least nine contiguous residues of the
specified charge type, a rare feature of a protein sequence; see
S.Karlin and B.E.Blaisdell, manuscript in preparation).
Independent of species, the net charge on average (and in
median terms) is slightly negative (see Table HI), with the marked
exception of the ORF sequences of the CMV genome. Paren-
thetically, CMV has >20 substantial (2:400 residues) ORFs with
significantly low positive charge usage. The 0.01 —0.99 range
of the total charge quantile distributions (Table HI) expands
(apparently not dependent on the numbers of sequences) with
the organism complexity: E.coli, 9.0-31%; yeast, 12.6-36.7%;
Drosophila, 11.0-44.2%; human, 11.2-40.3%. It is intriguing
that the total charge, on average, is reduced by >2% in CMV
proteins (and all human herpes virus ORFs, data not shown)
relative to species proteins.
Hydrophobic residue usages
The aggregate of strong hydrophobic aa (Leu, He, Val, Phe, Met)
is dominating among the prokaryotic (E.coli, B.subtilis) proteins
at every quantile level compared with all the eukaryotic species
examined (Figure 2). The viruses (CMV and vaccinia) at the
median level show about the same hydrophobic quantile points
as the prokaryotic species, but at the high quantile levels
hydrophobic residue usage is lower, similar to the eukaryotic
sequences. By contrast, the subclass of the human enzyme
quantile distribution dominates stochastically the corresponding
quantile distribution of the E.coli enzyme set (Table V). The
human nuclear protein class has (except at the minimum point)
the lowest (subordinating) hydrophobic quantile levels. In
particular, the human nuclear proteins are rich in charged and
general hydrophilic aa and also proline.
Amino add usages of strong and weak codon types
The strong codon aa group S = (Gly, Ala, Pro) is translated
from codon types SSN (S is the nucleotide C or G, N is any
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nucleotide) and the weak codon aa group comprises W = (Phe,
He, Lys, Asn, Tyr]. The multicellular eukaryotic protein sets
favor greater use of 5 aa compared with the (A + T-rich)
unicellular yeast and B.subtilis gene sequences. The reverse
stochastic ordering holds for W aa types (Table TV).
Comparison of the extremes of the quantile distributions
A varied picture is seen from the tails of the distributions. The
human protein sequences are partitioned into proteins that are
extremely rich or extremely poor in several residue types. Ten
different aa are observed to be absent from at least one human
protein, including the relatively abundant residue Thr. Only five
aa are absent from one or more E.coli sequences. At the high
usage levels, seven aa in human (Leu, Gly, Ala, Pro, Gin, Glu,
Lys) reach quantile frequencies >20%. In E.coli, only Leu and
Ala surpass this mark.
The percentage of proteins exhibiting quantile distributional
outliers, as defined in Materials and methods, varies greatly over
species: Drosophila (19.8%) > human (15.2%) > yeast (10.0%)
> E.coli (4.7%). The spectrum of aa giving rise to outliers is
strongly species-dependent. Outliers on the high side tend to be
hydrophilic and Gly in the eukaryotic species, but hydrophobic
in E.coli. Thus, the human set includes 20 proteins with very
extreme Glu usage, as compared with only one in E.coli.
Generally, the expanse of the tails of the distributions increases
with organismal complexity. This trend is reflected in the number
of aa in each species, with minima of 0% and maxima >20%:
E.coli, 5:2; yeast 6:5; Drosophila, 7:5; human, 10:7% (Table I).
Comparisons of average (or median) amino acid usages for
codon degeneracy classes
Degeneracy-1 group. Pervasively, Trp < Met. For the pro-
karyotes (E.coli, B.subtilis), Cys < Trp. Except for the human
collection, Cys is the second least frequently used aa.
Degeneracy-2 group. The quantile distributions of the two-
degeneracy (2-codon) aa are in the main congruent across species
except for Cys and Lys. The following nearly species invariant
median use pattern applies for the two-degeneracy aa: Lys, Glu
> Asp > Gin, Asn > Phe, Tyr > His > Cys. For the viruses,
the genome compositional biases have some influence.
Degeneracy-4 group. A weak general trend indicates Ala >
Gly > Val > Thr, Pro. Consistent with the weak base genome
bias, usage of Ala and Gly is low in yeast and very low in
vaccinia. Pro has low usage in prokaryotes and comparatively
high usage in human nuclear proteins. The use of Pro in humans
is high compared with that in E.coli. This probably reflects the
higher average G + C content of human genes and the profusion
of collagen-like and other extra-cellular proteins.
Degeneracy-6 group. The general trend entails Leu > Ser >
Arg. Deviations from this pattern occur for the nuclear proteins
where Ser > Leu.
Stochastic orderings within and between species
Glu > Asp (i.e. Glu usage is stochastically larger than Asp
usage, see Materials and methods) for most protein data sets.
Lys > Arg in yeast and vaccinia consonant with their weak base-
rich genomes. In most data sets there is no consistent stochastic
ordering pattern between Lys and Arg.
The stochastic ordering Phe > Tyr (exception vaccinia) holds
for most organisms examined despite the fact that Dayhoff et al.
(1978) rank Phe and Tyr the highest in aa exchange ratio.
For every quantile level the percent use of hydrophobics entails
the stochastic ordering (E.coli, B.subtilis) > yeast >- human
>• Drosophila (see Figure 2 and Table IV).
The quantile distributions of acidic versus basic residues (Table
C
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Fig. 2. Quantile distribution plots for E.coli and human aggregate hydrophobic aa.
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HI, Figure 4) for the human nuclear protein set cross at least Discussion
twice indicating no distinctive preferences in usages, although Invariants, contrasts and conundrums
total charge in nuclear proteins is relatively high compared with Various questions are raised by the data. How is aa usage affected
glycoproteins. by protein structure and genomic organization, aa biosynthesis,
o
a
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Fig. 3. Argininc and aspartate quantile distribution plots for human and E.coU enzyme sequences.
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Fig. 4. Acidic versus basic charge quantile distribution plots for human.
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relative abundances of free aa, tRNA availabilities and
evolutionary founder effects? We highlight and venture
interpretations and hypotheses on the principal findings.
Charge compositional biases
For all species sets, the median and mean net charges of a protein
are slightly negative ( 0.5%), whereas the human herpes virus
ORFs show on average a slightly positive net charge, ~ +0.3%
(Karlin and Brendel, 1992). In this study histidine with positively
charged residues was not included because in the normal cellular
ambience His is uncharged (Watson et al., 1987; Stryer, 1988).
In some previous publications, e.g. Karlin (1990) and Karlin
et al. (1991), positive charge clusters and runs with and without
His were analyzed. The total positive charge (Lys + Arg) per
protein is generally constant over species, ~ 11.5%. Individually,
the median Lys and Arg frequencies per protein vary across the
different species. For example, in the human set Arg is under-
represented, presumably because of CpG suppression, while in
E.coli Lys is under-represented (see Tables I and II). For the
major human herpes viruses, Lys is broadly under-used and Arg
broadly over-used as in the prokaryotic data sets (Karlin and
Brendel, 1992).
Of all aa Glu frequencies broadly show the greatest departure
from proportionality to codon degeneracy. It is curious that
evolution did not opt for more acidic aa codons. One might
speculate that the code was, in the main, fixed early in
evolutionary time, and compensated later by increased availability
of acidic tRNA and aminoacyl-tRNA synthetase molecules. In
contrast, the average basic residue usage (11.5 %) is much closer
to the average frequencies under random codon usage. The
average level of basic residues drops to ~ 10.3-10.7% for the
enzyme subsets of the human and E.coli sequences. This is
consistent with the observation that enzymes, in general, rarely
feature anomalous charge distributions (Karlin, 1990). In humans
the median Lys frequency, 5.7%, is significantly greater than
the 3.3% expected from random codon usage. The average of
degeneracy-2 arginine (codons AGR) is 2.4% for human but only
0.05% in E.coli, both much lower than expected from random
codon usage. But the average of degeneracy-4 arginine (codons
CGN)is - 3 . 2 % for human and -5 .6% for E.coli. It is striking
that frequencies of the four charged aa deviate more significantly
from proportionality to degeneracy than do any of the 16
uncharged aa.
Why is Glu stochastically larger than Asp, that is, used more
at all levels of use? From a structural viewpoint, Asp is
recognized as an a-helix breaker, whereas Glu is favorable to
a-helix formation. Moreover, the side chain of Glu involves two
methylene groups as against a single methylene group in Asp
providing greater conformational flexibility. Asp and Glu are
encoded by similar codon forms (GAR and GAY respectively),
but possibly the juxtaposition of purine—pyrimidine (AY) at
codon sites 2 and 3 is sterically unfavorable compared with the
purine—purine arrangement (AR). Apropos, polypurine runs for
unknown reasons tend to be over-represented in genomic
sequences (Bucher and Yagil, 1991).
Why do the majority of species proteins favor a net negative
charge (Karlin etal., 1991)? Residues on the surface of proteins
presumably need to be highly selective to be able to interact with
appropriate structures or avoid interacting with other structures.
From this perspective, the general net negative charge may better
avoid (mediated by electrostatic repulsion) undesirable inter-
actions with DNA, RNA, membrane surfaces and certain other
proteins. The extracellular milieu for metazoans is slightly
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alkaline, with pH - 7 . 2 - 7 . 4 (Roos, 1981), whereas the
intracellular pH is quite variable ranging from 5.0 to 7.2,
depending on tissue type and subcellular localizations (Alberts
et al., 1983; Stryer, 1988). One might speculate that enzyme
activity is 'optimum' at a pH similar to the pH of the host cells,
which in mammalian organisms is commonly slightly acidic.
Moreover, the protein negative charge tendency can contribute
in modulating secretion and intracellular transport, in inducing
transcriptional activation and generally in mediating rapid and
potent interactions of protein assemblages.
Use of aggregate hydrophobic aa
The major hydrophobic aa tend to be over-represented in the
prokaryotes {E.coli, B.subtilis) compared with eukaryotic species
(human, chicken, Xenopus, Drosophila, yeast) suggesting that
proteins enveloping a substantial hydrophobic core are relatively
more common in prokaryotes compared with eukaryotes (Figure
2), but this does not hold for the subclass of enzymes.
Human versus E.coli aa quantile distributions
A natural set of quantile distribution comparisons apply to human
versus E.coli for each residue type, because sample sizes are
about equal (751 and 710 sequences respectively) and both are
of broad functional distribution. The following stochastic
dominance orderings prevail: E.coli > human for residue types
Leu, lie, Val, Ala, Met, Arg, aggregate hydrophobics, basic,
emphasizing the major hydrophobics except for the aromatic Phe;
human > E.coli for residue types Cys, Pro, Ser, Glu, acidic
(all with relatively small side chains); no definite stochastic
ordering between human and E.coli is seen for the remaining
residue types. Strikingly, human enzymes > E.coli enzymes for
the aggregate of hydrophobic aa usages. For both the human and
E.coli enzyme sets, the quantile distribution of Arg is a stochastic
dilation (is more spread out, see Materials and methods) over
the quantile distribution of Asp (Figure 3). This property for
enzymes is persistent and independent of a bias for or against
arginine (e.g. CpG suppression). Such a stochastic dilation is not
true for the complete species protein collections.
The large numbers of stochastic orderings attest to the ancient
divergence between E.coli and human in aa usages. Quantile
distributions for the variable of sequence length (for proteins
> 200 residues) show that the median length is — 450 residues
for eukaryotic species sequences but only -370 residues for
E.coli sequences (data not shown). Consistent to the smaller
protein sizes, one might expect more statistical variation and more
extremes in aa usages for E.coli versus human sequences;
however, just the opposite is observed. The abundance of
extremes for the human sequences putatively reflects the greater
complexity of protein activities in the highly differentiated
eukaryotic cells.
Functional and structural determinants
To what extent do protein structural and functional requirements
determine aa frequencies? The results in Tables II—V suggest
that the human nuclear proteins emphasize hydrophilic residues
compared with cellular enzymes and glycoproteins in which
hydrophobic residues are foremost. It is generally accepted that
charged residues are either exposed to solvent or, if buried, are
likely to occur in pairs of opposite charge. From this perspective
and the expectation that most proteins would avoid unnecessary
assemblages and interactions, it is proposed that surface residues
tend to be more acidic than basic, thus reducing undesired
nonspecific ionic interactions. This hypothesis is consistent with
recent characterizations of aa 'environments' in protein structures
(Bowie et al., 1991). In their analysis, for an exposed or partially
Aralno acid usage in protein classes
exposed polar residue environment in many secondary structure
contexts, the scores of the aa Glu and Asp are positive, while
exposed environment scores of Lys and Arg are negative,
signifying that the acidic and basic residues are over-represented
and under-represented respectively in this 'surface' environment.
Amino acid biosynthesis and abundance
Do aa which are easier to synthesize and/or to be acquired from
external sources tend to be used more in proteins? How is this
reflected in intracellular aa abundances? Does the biosynthetic
pathway complexity (i.e. the number of enzymatic steps or the
nonessential or essential character of the particular aa) reflect
on aa usage? In this context, Glu is at the center of the web of
aa biosynthetic pathways and Asp is synthesized with but one
additional enzymatic step (Stryer, 1988) which may, in part,
account for the relatively high residue usages of Glu and Asp
(Glu stochastically greater than Asp). Consistent with their
significant over-representations, acidic residues often exhibit
unusual distributions in protein sequences, including a
preponderance of very long acidic runs especially pronounced
in connection with multiprotein complexes. Thus, many
fundamental nuclear and extra-cellular proteins carry unusually
long acidic runs or mixed charge runs favoring acidic residues.
This is particularly shown by proteins of the nucleolus and those
that are involved in RNA and DNA processing including
nucleolin, topoisomerase I, UBF, HMG1, UlsnRNP, U2snRNP,
myosin light chain kinase, troponins C and T, neurofilament
triplet L, lamins A, B and C, CENP-B, calreticulin and others.
Long anionic charge runs are also prevalent in many proteins
associated with ionic transport including voltage-gated Na+
channel, nicotinic acetylcholine receptor, AE1 and AE3 anionic
exchange proteins, Ca2+ transporter and others. In sharp
contrast, there are essentially no proteins with very long cationic
runs (S.Karlin and B.E.Blaisdell, manuscript in preparation). In
fact, the longest cationic run observed among the current human
protein collection (751 sequences) is a single nonapeptide (in GC
rich DNA binding factor), while there are many proteins carrying
anionic runs of > 14 residues length (e.g. nucleolin, myc,
calreticulin).
How are relative intracellular aa concentrations reflected in
aa usages? One might expect that cellular aa concentrations
correlate negatively with the complexity of the biosynthetic
pathway and correlate positively to the nonessential character of
the aa. From this perspective, Glu would be a relatively abundant
aa in all protein categories (species, function, localization), which
it is. In humans the essential aa vary greatly in abundance from
least, Tip, to most, Leu. The primary aa of the human
biosynthetic pathways, Asp, Glu, Ser, Ala and Gly, from which
others derived in part, rank 9, 6, 5, 3 and 2 out of 20 respectively.
Founder effects
Is there a remnant of founder effects relevant to aa usages? Wong
and Cedergren (1986) speculate that those aa derived directly
from the prebiotic synthesis manifest a higher frequency in
today's protein universe. There is the speculation that the earliest
peptides were composed of few aa which are the ones most
abundant today (Wong, 1988). The chemically and metabolically
simplest aa to accumulate are Gly, Asp, Glu and Ala and they
are, therefore, considered likely to have been the most abundant
in the primitive biosphere. Indeed, the average frequencies of
these aa tend to exceed expectations (Tables I and H) compared
with random codon usage. In particular, Ala and Gly are much
greater than expected in E.coli compared with human. Miller
(1986) estimated the relative abundances of aa found in meteorites
in decreasing rank order to be Gly, Ala, Val, Asp, Glu and Pro,
a ranking broadly concordant with aa usages. Evolutionary pro-
cesses have certainly expanded and diluted the protein repertoire
and reduced the amounts of the most over-represented aa. Just
as the genetic code is not frozen, as deduced from changing codon
assignments (Osawa et al., 1992), aa usages are likely to be in
a state of dynamic evolution, with new proteins continuously
being formed and others eliminated. Crick et al (1976) speculated
that in a methane-rich high temperature environment early transla-
tion events favored G + C-rich DNA sequences. This kind of
DNA distribution is not consistent with current representations
of aa usage (neither for averages nor extremes).
Relative highs and lows in aa usage
The predominance of leucine among protein sequences certainly
reflects its important role in hydrophobic core structures, in
transmembrane segments, in signal peptides and its prevalence
and stability in secondary and tertiary structures. The relatively
high alanine frequency in proteins also reflects on its a^hellx
stability and flexible hydrophobic properties. Interestingly, in
human nuclear proteins serine is foremost.
Cysteine exhibits unusual quantile distributions in many species,
sharply disparate between human and E.coli. Nearly 10% of the
E. coli proteins and ~ 5 % of the human proteins are devoid of
cysteine residues (these include many ribosomal proteins and
proteins functioning in mRNA processing). The dearth of
cysteine-rich proteins in E. coli may reflect the near absence of
extracellular proteins, whereas the human collection features
many cysteine-rich secreted proteins, e.g. blood-clotting factors,
proteins of the complement series and an assortment of glyco-
proteins. Even B.subtilis, in possession of relatively more secreted
proteins than E.coli, exhibits significantly low cysteine usage.
Apropros, no zinc finger proteins have been uncovered to date
in prokaryotes (Branden and Tooze, 1991; Luisi, 1992).
The quantile distributions of Gly, Pro and Cys in the human
protein sequences exhibit relatively long tails (especially at the
high extreme). This may merely reflect the protein sequence
sampling bias exemplified by large numbers of collagen types,
keratins and excreted proteins—the first two types abundant with
Gly and Pro, the latter type enriched with cysteine kringles, EGF-
like domains and disulfide bonds. The increasing discovery of
zinc finger or other metal ion coordinating nuclear proteins may
also be relevant.
The pervasive stochastic dominance ordering Phe >- Tyr, valid
for all species protein sets, is difficult to explain. The aa
occurrences of Phe and Tyr strongly correlate as do all pairs of
aromatic aa (Karlin and Bucher, 1992). Phe is a precursor of
Tyr in the path to acetyl CoA a precursor of many important
biological molecules. It is noteworthy that tyrosine is encoded
from the codon TAY where the dinucleotide TpA is pervasively
under-represented (Burge et al., 1992) and the least energetically
stable among all dinucleotides (Bresslauer et al., 1986; Delcourt
and Blake, 1991). Moreover, tyrosine is often an important
phosphorylation target site in effecting protein conformational
and functional changes which may explain its limited judicious
use compared with phenylalanine.
Further data studies
(i) It would be informative to ascertain quantile distributions for
the various protein classes in other aa classifications including
the chemical, functional, structural and size alphabets (for
definitions see Karlin et al., 1991). (ii) The methodology of
quantile distributions can also be applied to general DNA
sequences in various alphabets (e.g. purine, pyrimidine) and to
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gene sequences with respect to codons, or silent site frequencies,
etc. (iii) Multivariate quantile distributions are also feasible,
e.g. examining simultaneously usage frequencies for charge, size
and hydrophobicity. (iv) It would be desirable to extend quantile
distributions and correlation analyses to other natural function
or structure protein classes including sequences of the super-
immune family, proteins of cytoskeletal associations, kinases,
developmental genes and transcription factors, (v) With respect
to evolutionary perspectives, quantile tables of homologous
proteins (e.g. the globin family) would be of interest, (vi) Other
variables associated with protein classes for which quantile
distributions are natural include the length and kDa assessments
of a protein sequence, multiplet counts (Karlin and Brendel, 1992)
and observations or predictions on secondary structures (number
of a-helices, /3-strands).
Possible experiments suggested by the data and theory
(i) It is paradoxical that Lys and Arg usage tend to be uncorrelated
or negatively correlated but are scored high in the PAM exchange
matrix (Dayhoff et al., 1978). Our previous discussion
underscored chemical, shape and ionic differences. It would seem
interesting to conduct large scale replacements of Lys — Arg
in various protein classes, particularly those with extreme
frequencies of Lys and Arg, and evaluate consequences on
function and structure, (ii) The almost universal stochastic
ordering Glu > Asp indicates preference of Gluover Asp at all
levels of use. Our previous discussion suggested possible reasons
for this. Again, focused studies of replacements of Glu — Asp
might help elucidate the relative role of Glu versus Asp. (iii)
Similar replacement experiments relevant to the universal
stochastic ordering Phe > Tyr could be of interest, (iv) Leu is
broadly of abundant use (overall it has the highest frequency in
proteins). To what extent and for which protein species can Val
or lie substitute or not substitute for Leu or Ala for Leu? (v)
Ser entails the highest frequency in mammalian nuclear proteins.
What substitutions preserve functions in these cases?
Quantile implications for sequence comparisons
Contrary to intuition, compositional differences appear to be more
pronounced between species than between function classes. This
has obvious implications for phylogenetic reconstructions as well
as for the statistical evaluation of weak protein sequence
similarities. Overestimates of evolutionary distances may result
from not taking divergent species-specific compositional
constraints into account. The significance of high scoring matches
between segments of similarly biased aa composition might be
better evaluated on the basis of compositional extremes in the
respective species. In this context we might propose sequence
comparisons based on asymmetric PAM matrix scores (Dayhoff
et al., 1978) as a constituent of a realistic model of protein
sequence evolution. The sharp differences of 'strong minus weak'
codon types in CMV versus vaccinia quantile distributions may
be explained from this perspective.
Many authors, as reviewed in Introduction, have written on
variation in the aa composition of proteins generally in terms of
averages. This paper shows that composition quantile distribu-
tions and the recognition of stochastic dominance relations allow
more refined and robust comparative assessments of the aa
compositional variation of proteins. These include observations
on the universal stochastic dominance of glutamate over aspartate
and of phenylalanine over tyrosine, and the sharp contrasts of
usage associations between acidic residues versus usage
associations between basic residues. Our interpretations and
speculations focused on invariants and contrasts of the aa
compositional spectrum in relation to species, function, cellular
and tissue localization, biochemical and steric attributes,
complexity of the different aa biosynthetic pathways, aa relative
abundances, tRNA availabilities, translation fidelity and
efficiency, early historical events, and evolutionary processes.
To what extent some of the results may be artifacts of sample
bias in the current collections of sequences of the databases is
unclear. The acquisition of more complete genomes (or even
chromosomes) over the next decade can help in resolving
uncertainties through applications of the concepts and methods
of quantile distributions of enhanced power.
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